Loading...
•
Mar 31
Rockwell Medical Q1 2025 Earnings Report
Rockwell Medical reported a net loss but maintained stable gross profit in Q1 2025 amid a drop in revenue.
Key Takeaways
Despite losing its largest customer, Rockwell Medical kept gross profit steady year-over-year and slightly narrowed its net loss, supported by operational efficiencies and automation initiatives.
Revenue declined 17% YoY to $18.9M due to a major customer transition.
Gross profit remained flat at $3.0M despite the lower revenue base.
Net loss improved to $1.5M from $1.7M in Q1 2024.
Adjusted EPS was -$0.01 and Adjusted EBITDA came in at -$0.4M.
Rockwell Medical
Rockwell Medical
Forward Guidance
Rockwell reaffirmed full-year 2025 guidance despite Q1 revenue decline, expecting margin stability and operational improvements.
Positive Outlook
- Maintained full-year net sales guidance of $65M–$70M.
- Confirmed gross margin target range of 16%–18%.
- Forecast adjusted EBITDA to range between -$0.5M and $0.5M.
- Increased automation supports expense reduction.
- New bicarbonate cartridge product expands dialysis portfolio.
Challenges Ahead
- Q1 revenue down due to major customer transition.
- Cash decreased by $4.3M from Q4 2024.
- Continued operating loss in the quarter.
- Negative free cash flow driven by timing of payments.
- Seasonal expense pressures weighed on Q1 profitability.